In today’s recent session, 123.98 million shares of the Spero Therapeutics Inc (NASDAQ:SPRO) have been traded, and its beta is 0.25. Most recently the company’s share price was $2.35, and it changed around $1.67 or 244.57% from the last close, which brings the market valuation of the company to $131.39M. SPRO at last check was trading at a discount to its 52-week high of $1.53, offering almost 34.89% off that amount. The share price’s 52-week low was $0.51, which indicates that the recent value has risen by an impressive 78.3% since then. We note from Spero Therapeutics Inc’s average daily trading volume that its 10-day average is 95570.0 shares, with the 3-month average coming to 129.39K.
Spero Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended SPRO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
Instantly SPRO has been showing a green trend so far today with a performance of 244.57% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently up 128.16% year-to-date, but still up 245.49% over the last five days. On the other hand, Spero Therapeutics Inc (NASDAQ:SPRO) is 230.99% up in the 30-day period. We can see from the shorts that 0.65 million shares have been sold at a short interest cover period of 3.79 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.67%. Spero Therapeutics Inc earnings are expected to increase by 111.42% in 2025, but the outlook is positive 7.97% per year for the next five years.
SPRO Dividends
Spero Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-May-12.
Spero Therapeutics Inc (NASDAQ:SPRO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 24.32% of Spero Therapeutics Inc shares, and 30.12% of them are in the hands of institutional investors. The stock currently has a share float of 39.80%. Spero Therapeutics Inc stock is held by 47.0 institutions, with ANSON FUNDS MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 7.007% of the shares, which is about 3.75 million shares worth $4.88 million.
VANGUARD GROUP INC, with 3.3079% or 1.77 million shares worth $2.3 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.17 shares worth $2.79 million, making up 2.09% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 587.34 shares worth around $1.4 million, which represents about 1.05% of the total shares outstanding.
